Zobrazeno 1 - 10
of 129
pro vyhledávání: '"Martinotti R"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rosina, F., Conoscitore, P., Smedile, A., Mangia, A., Borghesio, E., Martinotti, R., Andriulli, A., Rizzetto, M.
Publikováno v:
In Digestive and Liver Disease 2002 34(4):285-289
Autor:
Cosentini, R, Brambilla, AM, ALIBERTI, STEFANO, Bignamini, A, Nava, S, Maffei, A, Martinotti, R, Tarsia, P, Monzani, V, Pelosi, P.
Objective: Our objective was to evaluate the efficacy of noninvasive continuous positive airway pressure(CPAP) delivered by helmet in improving oxygenation in comparison with oxygen therapy in community-acquired pneumonia(CAP). Methods: This was a mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::24852088df45bc2edce2c0cb8fa61b58
http://hdl.handle.net/11585/161640
http://hdl.handle.net/11585/161640
Autor:
Angelo Andriulli, Mario Rizzetto, Floriano Rosina, P. Conoscitore, Alessandra Mangia, Antonina Smedile, E. Borghesio, Martinotti R
Publikováno v:
Digestive and Liver Disease. 34:285-289
Background . Thymic humoral factor gamma 2 is a thymus-derived synthetic octapeptide, shown to be effective in chronic hepatitis B virus infection; as the latter is needed to support hepatitis D virus, thymic humoral factor-gamma 2 may have a therape
Autor:
Cosentini, R., Brambilla, A. M., Aliberti, S., Bignamini, A., Nava, S., Maffei, A., Martinotti, R., Tarsia, P., Monzani, V., Pelosi, PAOLO PASQUALINO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6e36facf53f22f172f371f481b155f74
http://hdl.handle.net/11383/1716390
http://hdl.handle.net/11383/1716390
Publikováno v:
Europe PubMed Central
Gastric carcinogenesis involves a slow but continuous, stepwise evolution from superficial gastritis to glandular atrophy, metaplasia, dysplasia, and finally, to adenocarcinoma. In 1994, the International Agency for Research on Cancer defined Helicob
Publikováno v:
Minerva medica (Testo stamp.) 97 (2006): 31–38.
info:cnr-pdr/source/autori:Pellicano, R; Mladenova, I; Martinotti, R; Fagoonee, S; Rizzetto, M/titolo:Cancro gastrico e Helicobacter pylori: un punto di vista interdisciplinare./doi:/rivista:Minerva medica (Testo stamp.)/anno:2006/pagina_da:31/pagina_a:38/intervallo_pagine:31–38/volume:97
info:cnr-pdr/source/autori:Pellicano, R; Mladenova, I; Martinotti, R; Fagoonee, S; Rizzetto, M/titolo:Cancro gastrico e Helicobacter pylori: un punto di vista interdisciplinare./doi:/rivista:Minerva medica (Testo stamp.)/anno:2006/pagina_da:31/pagina_a:38/intervallo_pagine:31–38/volume:97
Gastric carcinogenesis involves a slow but continuous, stepwise evolution from superficial gastritis to glandular atrophy, metaplasia, dysplasia, and finally, to adenocarcinoma. In 1994, the International Agency for Research on Cancer defined Helicob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=cnr_________::cfa9396c44c467aaebb9ba0281639c9f
http://www.cnr.it/prodotto/i/318101
http://www.cnr.it/prodotto/i/318101
Publikováno v:
Minerva medica. 92(5)
Hepatocellular carcinoma (HCC) is the fourth cause of death for cancer, the first in northern Africa and is the eighth tumor for incidence in the world. Risk factors are: liver cirrhosis, HBV, HCV and natural toxins (i.e. aflatoxin). A screening prog
A patient with intractable posthypoxic myoclonus (Lance-Adams syndrome) treated with sodium oxybate.
Autor:
Arpesella R, Dallocchio C, Arbasino C, Imberti R, Martinotti R, Frucht SJ, Arpesella, R, Dallocchio, C, Arbasino, C, Imberti, R, Martinotti, R, Frucht, S J
Publikováno v:
Anaesthesia & Intensive Care; Mar2009, Vol. 37 Issue 2, p314-318, 5p
Autor:
Rosina, F., Alaria, P., Castelli, S., Dirindin, N., Rocca, G., Actis, Gc, Borelli, R., Ciancio, Alessia, DE BERNARDI, W., Fornasiero, S., Lavezzo, B., Lagget, M., Martinotti, R., Marzano, A., Ottobrelli, A., Sostegni, R., Rizzetto, Mario, Verme, G.
Publikováno v:
The Italian journal of gastroenterology. 28(7)
The Prospective Payment System uses Diagnosis-Related Groups (DRG) as a reimbursement system. DRG 202 is a disease-related group including liver cirrhosis as a whole. Patients referring to the inpatient unit complain of variable severity and complica